Endocrinology Diabetes & Metabolism · 2025 · 10 citations · 31 references
MedicineCardiologyInternal MedicineClinical CardiologyDiabetologyPreventive CardiologyCardiovascular DiseaseCardiovascular RiskCoronary Artery DiseaseDiabetes MellitusIschemic Heart DiseaseCardiometabolic DiseaseCoronary Heart Disease EpidemiologyDiabetes-associated Cardiac RiskFasting Glycemia
BACKGROUND: Despite previous studies, the relationship between the triglyceride-glucose (TyG) index and coronary artery disease (CAD) is still undetermined. So we aimed to investigate the association between the TyG index and CAD. METHOD: A total of 2346 subjects were enrolled in the study and were categorised into 5: those with no CAD, angiogram negative (Ang-) patients, those with single-vessel disease (SVD), or two-vessel disease (2VD) or three-vessel disease (3VD). Demographic characteristics, disease history and biochemical investigations were recorded. TyG index was calculated as Ln [fasting TG (mg/dL) × fasting glucose (mg/dL)/2]. RESULTS: Adjusted regression models demonstrated that the odds of 3VD (OR, 5.847; 95% CI, 4.391-7.784), 2VD (OR, 4.943; 95% CI, 3.597-6.791), SVD (OR, 4.722; 95% CI 3.448-6.647) and a negative coronary angiogram (OR, 3.137; 95% CI, 2.431-4.049), increased significantly per each unit elevation of the TyG index, compared to the healthy participants. Also, the odds for being 3VD (1.864, 95%CI 1.402-2.477, p-value < 0.001), 2VD (1.575, 95%CI 1.143-2.171, p-value = 0.005) and SVD (1.505, 95%CI 1.097-2.065, p-value = 0.011) were increased significantly by one-unit elevation of TyG index, compared to Ang- group. CONCLUSION: Our study demonstrates a significant association between elevated TyG index and the presence and severity of CAD. Higher TyG index values were consistently linked to an increased likelihood of multivessel CAD, especially in diabetic patients. These findings suggest that the TyG index could serve as a valuable marker for assessing CAD risk and stratification.
31
Luis E. Simental‐Mendía, Martha Rodríguez‐Morán, Fernando Guerrero‐Romero · Metabolic Syndrome and Related Disorders · 2008 · 2.5K citations
Medicine, Endocrinology, Diabetology +15
Fernando Guerrero‐Romero, Luis E. Simental‐Mendía, Manuel González-Ortı́z et al. · The Journal of Clinical Endocrinology & Metabolism · 2010 · 2.3K citations · Full text
Medicine, Endocrinology, Diabetology +15
Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.
Enzo Bonora, Stefan Kiechl, Johann Willeit et al. · Diabetes · 1998 · 844 citations
Atherosclerosis: process, indicators, risk factors and new hopes.
Mahmoud Rafieian‐Kopaei, Mahbubeh Setorki, Monir Doudi et al. · PubMed · 2014 · 824 citations · Full text